Sunder Biomedical Tech Co

Sunder Biomedical Tech Co Net Debt

The Net Debt of Sunder Biomedical Tech Co (4115.TWO) as of Oct 26, 2026 is 132.24 M TWD. In the previous year, Net Debt was 255.88 M TWD — a change of -48.32% (lower).

Net Debt

132.24 MTWD

YoY

-48.32%

Last updated:

Net Debt of Sunder Biomedical Tech Co is 2025 132.24 M TWD. Net Debt of Sunder Biomedical Tech Co was 2024 255.88 M TWD. It decreases by -48.32% lower compared to the previous year.

The Sunder Biomedical Tech Co Net Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt
Date
Net Debt
Jan 1, 2019
345.07 M TWD
Jan 1, 2020
400.89 M TWD
Jan 1, 2021
319.12 M TWD
Jan 1, 2022
316.41 M TWD
Jan 1, 2023
327.47 M TWD
Jan 1, 2024
255.88 M TWD
Jan 1, 2025
132.24 M TWD
The Sunder Biomedical Tech Co Net Debt history
YEARNet DebtYoY
132.24 MTWD-48.32%
255.88 MTWD-21.86%
327.47 MTWD+3.49%
316.41 MTWD-0.85%
319.12 MTWD-20.40%
400.89 MTWD+16.18%
345.07 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sunder Biomedical Tech Co Stock analysis

What does Sunder Biomedical Tech Co do? Sunder Biomedical Tech Co Ltd manufactures and sells medical consumables including blood circuit catheters, puncture needles, infusion sets, suction tubing, dosing sets, waste fluid collection bags, and protective covers. The company also produces laparoscopic smoke filters, suction sets, pick-up bags, and medical grade materials such as PVC pellets, NON-diethylhexyl phthalate (DEHP) PVC, and other medical components. Additionally, Sunder Biomedical offers sterilization and laboratory services, along with foundry services for masks, tubes, and nucleic acid extraction well tray consumables. The primary buyers of Sunder Biomedical's products are healthcare facilities, hospitals, and medical institutions requiring disposable medical equipment and supplies. These clients purchase medical consumables for routine procedures, surgical operations, and patient care. The company's focus on medical grade materials ensures compliance with healthcare standards, making its products essential for medical professionals. Sunder Biomedical's revenue streams include direct sales of medical consumables, sterilization services, and foundry services for specialized medical components. The company targets the healthcare sector, particularly hospitals and clinics, where demand for reliable, high-quality disposable medical products is consistent. By providing a comprehensive range of medical supplies, Sunder Biomedical caters to the operational needs of healthcare providers across various medical specialties. Sunder Biomedical Tech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sunder Biomedical Tech Co stock

Net Debt of Sunder Biomedical Tech Co is 132.24 M TWD in 2025.

Net Debt of Sunder Biomedical Tech Co changed from 255.88 M TWD to 132.24 M TWD, representing a -48.32% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt Sunder Biomedical Tech Co since 2006 – with annual values, charts, and detailed analysis.

Net debt is total debt minus cash and cash equivalents. It shows the actual debt burden after accounting for available liquid resources.

Net Debt's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Debt's Sunder Biomedical Tech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Sunder Biomedical Tech Co

All Key Metrics — Sunder Biomedical Tech Co